Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma Meeting Abstract

  

Authors:	Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; Nath, K.; Rajeeve, S.; Lesokhin, A. M.; Korde, N.; Tan, C. R.; Hashmi, H.; Hassoun, H.; Maclachlan, K. H.; Shah, U. A.; Hultcrantz, M.; Hamadeh, I. S.; Giralt, S. A.; Chung, D. J.; Landau, H. J.; Scordo, M.; Shah, G. L.; Usmani, S. Z.; Mailankody, S.; Shahid, Z.
Abstract Title:	Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma
Meeting Title:	66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	144
Issue:	Suppl. 1
Meeting Dates:	2024 Dec 7-10
Meeting Location:	San Deigo, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2024-11-05
Start Page:	6935
End Page:	6936
Language:	English
ACCESSION:	WOS:001415718800015
DOI:	10.1182/blood-2024-207977
PROVIDER:	wos
Notes:	Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/223555